Kendra S. Carmon

The University of Texas MD Anderson Cancer Center

Also affiliated with Houston Health and Human Services Department, Brown Foundation, University of Houston, The University of Texas Health Science Center at Houston

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Development of a bioassay for detection of Wnt-binding affinities for individual frizzled receptors”.

Development of a bioassay for detection of Wnt-binding affinities for individual frizzled receptors

Analytical Biochemistry(2010)10.1016/j.ab.2010.03.009

N/A

2.1DataRank · unranked

39 citations

David S. Loose, Kendra S. Carmon

Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.11.089177

N/A

0DataRank · unranked

2 citations

Sheng Zhang, Tressie A. Posey, Ling Wu, Wangsheng Yu, Qingyun J. Liu +2 more

Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.100261

N/A

0DataRank · unranked

34 citations

Sheng Zhang, Tressie A. Posey, Joan Jacob, Ling Wu, Wangsheng Yu +4 more

An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.11.503187

N/A

0DataRank · unranked

10 citations

Liezl E. Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J. Liu +3 more

Loss of LGR5 through plasticity or gene ablation is associated with therapy resistance and enhanced MET-STAT3 signaling in colorectal cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.01.482539

N/A

0DataRank · unranked

2 citations

Joan Jacob, Ashlyn Parkhurst, Shraddha Subramanian, Liezl E. Francisco, Zhengdong Liang +2 more

Development of a Novel Combination Therapy targeting MET and LGR5 to overcome Colorectal Cancer Resistance

(2022)10.52519/00086

N/A

0DataRank · unranked

2 citations

Tressie A. Posey, Joan Jacob, Kendra S. Carmon, Shradhha Subramanian

An antibody–drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

British Journal of Cancer(2023)10.1038/s41416-023-02192-3

N/A

0DataRank · unranked

24 citations

Liezl E. Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J. Liu +3 more

Unlike LGR4, LGR5 potentiates Wnt–β-catenin signaling without sequestering E3 ligases

Science Signaling(2020)10.1126/scisignal.aaz4051

N/A

0DataRank · unranked

51 citations

Ling Wu, Jianghua Tu, Wangsheng Yu, Yukimatsu Toh, Kendra S. Carmon +2 more

G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors

Cellular and Molecular Life Sciences(2024)10.1007/s00018-024-05416-8

N/A

0DataRank · unranked

8 citations

Ana L. Moreno-Salinas, Andréanne Laniel, Brian J. Holleran, Charlotte Avet, Joan Jacob +6 more

The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases

Pharmaceutics(2024)10.3390/pharmaceutics16070890

N/A

0DataRank · unranked

14 citations

Cara Guernsey-Biddle, Shraddha Subramanian, Joan Jacob, Kendra S. Carmon, Peyton C. High

Antitumor Activity of a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma

Pharmaceutics(2024)10.3390/pharmaceutics16070943

N/A

0DataRank · unranked

10 citations

Yukimatsu Toh, Adela M. Aldana, Jake J. Wen, Ling Wu, Joan Jacob +5 more

G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors

Research square(2024)10.21203/rs.3.rs-4869264/v1

N/A

0DataRank · unranked

0 citations

Ana Lilia Moreno Salinas, Andréanne Laniel, Brian J. Holleran, Charlotte Avet, Joan Jacob +6 more

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102363

N/A

0DataRank · unranked

2 citations

Zhengdong Liang, Cara Guernsey-Biddle, Shraddha Subramanian, Yueh-Ming Shyu, Adela M. Aldana +3 more

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.18.660406

N/A

0DataRank · unranked

2 citations

Zhengdong Liang, Cara Guernsey-Biddle, Shraddha Subramanian, Yueh-Ming Shyu, Adela M. Aldana +3 more

Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0415

N/A

0DataRank · unranked

17 citations

Joan Jacob, Ashlyn Parkhurst, Shraddha Subramanian, Liezl E. Francisco, Zhengdong Liang +2 more